Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats

    Lin Zhou, Fengjuan Yan, Rui Jiang, Jing Liu, Limin Cai, Yongchen Wang
    TLDR Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.
    The study investigated the therapeutic effects of Nrf-2-modified hair-follicle mesenchymal stem cells (HF-MSCs) on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in rats. The rats were divided into five groups, including a healthy control and UC model rats treated with normal saline, Nrf-2, HF-MSCs, or Nrf-2-expressing HF-MSCs. Results showed that the Nrf-2-expressing HF-MSCs group exhibited the most significant improvement in terms of intestinal stem cell expression, inflammatory and anti-inflammatory factors, and disease activity index scores. This suggested that Nrf-2-expressing HF-MSCs could be a promising new treatment for UC.
    Discuss this study in the Community →